Active Shortage

MITOMYCIN FOR INJECTION

TEVA CANADA LIMITED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of MITOMYCIN FOR INJECTION in Canada?

Yes. MITOMYCIN FOR INJECTION 20MG has an active shortage reported to Health Canada (last updated October 14, 2021).

Why is MITOMYCIN FOR INJECTION not available?

The reason the manufacturer reported: Demand increase for the drug.

When will MITOMYCIN FOR INJECTION be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file2 products

Affected strength20MG

Report last updated2021-10-14

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

MITOMYCIN FOR INJECTION, USP

HIKMA CANADA LIMITED

20MG · DIN 02531941

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

MITOMYCIN FOR INJECTION USP

ACCORD HEALTHCARE INC

20MG · DIN 02464691

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02230451

Strength

20MG

Dosage Form

POWDER FOR SOLUTION

Route

INTRAVENOUS INTRAVESICAL

Active Ingredient

MITOMYCIN

See all MITOMYCIN products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2021-10-14

Active Shortage

Demand increase for the drug.

Other Products from TEVA CANADA LIMITED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETAMINOPHEN WITH CODEINE - CAPLET

DIN 02143933

DIN 00834319

3.5MG · DIN 02438399

0.5MG · DIN 02301407

100MG · DIN 02420155

200MG · DIN 02420163